Compare MNKD & NN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MNKD | NN |
|---|---|---|
| Founded | 1991 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 2004 | N/A |
| Metric | MNKD | NN |
|---|---|---|
| Price | $6.00 | $16.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $10.08 | N/A |
| AVG Volume (30 Days) | ★ 2.8M | 1.2M |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.47 | N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $313,787,000.00 | $5,539,000.00 |
| Revenue This Year | $21.54 | N/A |
| Revenue Next Year | $22.21 | N/A |
| P/E Ratio | $61.14 | ★ N/A |
| Revenue Growth | ★ 17.43 | 11.61 |
| 52 Week Low | $3.38 | $9.05 |
| 52 Week High | $7.07 | $18.54 |
| Indicator | MNKD | NN |
|---|---|---|
| Relative Strength Index (RSI) | 66.29 | 70.47 |
| Support Level | $5.59 | $13.41 |
| Resistance Level | $5.90 | $17.20 |
| Average True Range (ATR) | 0.19 | 0.77 |
| MACD | 0.06 | 0.34 |
| Stochastic Oscillator | 99.47 | 88.62 |
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
NextNav Inc provides GPS service. The company NextNav TerraPoiNT system keeps critical infrastructure resilient with reliable Position, Navigation, and Timing services in the absence of GPS.